Ali Behbahani, 10% Owner at Regulus Therapeutics Inc. (RGLS), bought 2,273,408 shares at $1.08 ($2.5M) on 2019-05-07, disclosed to the SEC on 2019-05-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.08 | 1,136,704 | $1.2M | 50.0% |
| 2 | $1.08 | 1,136,704 | $1.2M | 50.0% |
| Total | $1.08 avg | 2,273,408 | $2.5M | 100% |
| Filing → |
| ADAP | SELL | 2025-08-19 | $342K | — | Filing → |
| MBX | BUY | 2024-09-17 | $8.0M | — | Filing → |
| SVRA | BUY | 2023-07-19 | $1000K | — | Filing → |